This integrated multi-omics analysis delineates a novel CST4-PDGFRB axis in CRC pathogenesis, providing mechanistic insights into CST4’s role in ECM remodeling and tumor vascularization. This evidence concerns the gene CST4 and colorectal carcinoma.